Marketplace®

Daily business news and economic stories

Here’s why there’s a shortage of EpiPens

The Food and Drug Administration is trying to help mitigate the shortage of EpiPens, those auto-injecting devices used to treat allergic reactions to things like peanuts and bee stings. It’s extended by four months the expiration date for some EpiPen products. The FDA got data from EpiPen maker Mylan that convinced them some of the […]

The Food and Drug Administration is trying to help mitigate the shortage of EpiPens, those auto-injecting devices used to treat allergic reactions to things like peanuts and bee stings. It’s extended by four months the expiration date for some EpiPen products. The FDA got data from EpiPen maker Mylan that convinced them some of the devices already on the market will work a bit longer.

Click the audio player above to hear the full story. 

Related Topics

Latest Episodes

View All Shows
  • Marketplace
    4 hours ago
    25:19
  • Make Me Smart
    10 hours ago
    19:00
  • Marketplace Morning Report
    12 hours ago
    6:55
  • Marketplace Tech
    17 hours ago
    8:33
  • This Is Uncomfortable
    3 days ago
    56:05
  • Million Bazillion
    24 days ago
    32:45